| Product Code: ETC7611717 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Liraglutide Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Liraglutide Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Liraglutide Market - Industry Life Cycle |
3.4 Iraq Liraglutide Market - Porter's Five Forces |
3.5 Iraq Liraglutide Market Revenues & Volume Share, By Brands, 2021 & 2031F |
4 Iraq Liraglutide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Iraq |
4.2.2 Growing awareness about the benefits of liraglutide in managing diabetes |
4.2.3 Favorable government initiatives to promote diabetes management |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in certain regions of Iraq |
4.3.2 High cost of liraglutide treatment for some patients |
4.3.3 Cultural and religious beliefs impacting the acceptance of medical treatments |
5 Iraq Liraglutide Market Trends |
6 Iraq Liraglutide Market, By Types |
6.1 Iraq Liraglutide Market, By Brands |
6.1.1 Overview and Analysis |
6.1.2 Iraq Liraglutide Market Revenues & Volume, By Brands, 2021- 2031F |
6.1.3 Iraq Liraglutide Market Revenues & Volume, By Victoza, 2021- 2031F |
6.1.4 Iraq Liraglutide Market Revenues & Volume, By Saxenda, 2021- 2031F |
7 Iraq Liraglutide Market Import-Export Trade Statistics |
7.1 Iraq Liraglutide Market Export to Major Countries |
7.2 Iraq Liraglutide Market Imports from Major Countries |
8 Iraq Liraglutide Market Key Performance Indicators |
8.1 Number of diabetes cases diagnosed annually in Iraq |
8.2 Percentage increase in prescriptions of liraglutide by healthcare providers |
8.3 Patient adherence rate to liraglutide treatment |
8.4 Number of healthcare facilities offering liraglutide treatment |
8.5 Level of patient education and awareness programs conducted by healthcare organizations |
9 Iraq Liraglutide Market - Opportunity Assessment |
9.1 Iraq Liraglutide Market Opportunity Assessment, By Brands, 2021 & 2031F |
10 Iraq Liraglutide Market - Competitive Landscape |
10.1 Iraq Liraglutide Market Revenue Share, By Companies, 2024 |
10.2 Iraq Liraglutide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here